Chinese firm's COVID-19 drug claims draw scientists' scepticism

Chinese biotech firm Kintor Pharmaceutical Limited saw its stock price jump by more than 20% the day after it announced on April 25 that it had "completed the first patient enrolment and dosing" in a late-stage US clinical trial of its experimental COVID-19 treatment.

from bdnews24.com - Home https://ift.tt/3waIYmt